Clinical Trial Update: Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating lung clearance index in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; the study has terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis | Phase 4 | Status: TERMINATED | Results posted: 2018-10-09